Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation

Journal of Infectious Diseases

Volumn 187, Issue 1, 2003, Pages 117-123

  Lewis, Kaeryn N ^a,b   Liao, Reiling ^b   Guinn, Kristi M ^b   Hickey, Mark J ^b   Smith, Sherilyn ^a   Behr, Marcel A ^c   Sherman, David R ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; BCG VACCINE; CELLS, CULTURED; GENE DELETION; GENES, BACTERIAL; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VACCINES, ATTENUATED;

EID: 0037219942     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345862     Document Type: Article

References (43)

1. Bloom BR, Fine PEM. The BCG experience: Implications for future vaccines against tuberculosis. In: Bloom BR, ed. Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: American Society for Microbiology Press, 1994:531-57.
2. Fine PEM, Carneiro IAM, Milstien IB, Clements CJ. Issues Relating to the Use of BCG in Immunization Programmes. Available at: http://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf; last accessed 15 November 2002.
3. Casanova JL, Blanche S, Emile JF, et al. Idiopathic disseminated bacillus Calmette-Guérin infection: A French national retrospective study. Pediatrics 1996; 98:774-8.
4. Huebner RE. Bacillus of the Calmette and Guérin (BCG) vaccine. In: Rom WN, Garay SM, eds. Tuberculosis. Boston: Little, Brown & Company, 1996:893-904.
5. Zumla A, Mwaba P, Squire SB, Grange JM. The tuberculosis pandemic: Which way now? J Infect 1999; 38:74-9.
6. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178:1274-82.
7. Philipp WJ, Nair S, Guglielmi G, Lagranderie M, Gicquel B, Cole ST. Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology 1996; 142:3135-45.
8. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284:1520-3.
9. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999; 32:643-55.
10. Mostowy S, Cousins D, Brinkman J, Aranaz A, Behr MA. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis 2002; 186:74-80.
11. Brosch R, Gordon SV, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002; 99:3684-9.
12. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-44.
13. Sherman DR, Sabo PJ, Hickey MJ, et al. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci USA 1995; 92:6625-9.
14. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc Natl Acad Sci USA 2001; 98:7534-9.
15. Yuan Y, Crane DD, Simpson RM, et al. The 16-kDa α-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 1998; 95:9578-83.
16. Smith S, Liggitt D, Jeromsky E, Tan X, Skerrett SJ, Wilson CB. Local role for tumor necrosis factor α in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect Immun 2002; 70:2082-9.
17. Russell DG. Mycobacterium tuberculosis: Here today, and here tomorrow. Nat Rev Mol Cell Biol 2001; 2:569-77.
18. Silver RF, Li Q, Ellner JJ. Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumor necrosis factor α but not with evasion of lymphocyte-dependent monocyte effector functions. Infect Immun 1998; 66:1190-9.
19. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 1999; 179:1213-7.
20. Medina E, North RJ. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 1998; 93:270-4.
21. North RJ. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis 1995; 172:1550-3.
22. Garay SM. Pulmonary tuberculosis. In: Rom WN, Garay SM, eds. Tuberculosis. Boston: Little, Brown and Company, 1996:373-412.
23. McMurray DN, Collins FM, Dannenberg AM Jr, Smith DW. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 1996; 215:157-79.
24. Orme IM, McMurray DN. The immune response to tuberculosis in animal models. In: Rom WN, Garay SM, eds. Tuberculosis. Boston: Little, Brown and Company, 1996:269-80.
25. North RJ, Ryan L, LaCource R, Mogues T, Goodrich ME. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect Immun 1999; 67:5483-5.
26. Calmette A, Guérin C. Recherches expérimentales sur la défense de l'organisme contre l'infection tuberculeuse. Ann Inst Pasteur 1911; 25:625-41.
27. Wards BJ, de Lisle GW, Collins DM. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuber Lung Dis 2000; 80:185-9.
28. Lee MH, Pascopella L, Jacobs WRJ, Hatfull GF. Site-specific integration of mycobacteriophage L5: Integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. Proc Natl Acad Sci USA 1991; 88:3111-5.
29. Moreira AL, Tsenova L, Murray PJ, et al. Aerosol infection of mice with recombinant BCG secreting murine IFN-γ partially reconstitutes local protective immunity. Microb Pathog 2000; 29:175-85.
30. Rozenberg AM. Investigations of biological activity of the BCG substrains in an experiment. Probl Tuberk 1971; 49:80-5.
31. Frenette M, Portelance V, Beaudet R. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: No correlation with their antitumour activity. Microbios 1983; 36:173-82.
32. Lagranderie M, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun1996; 64:1-9.
33. Dunn PL, North RJ. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J Med Microbiol 1996; 45:103-9.
34. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995;63:1710-7.
35. Ahmad S, Amoudy HA, Thole JE, Young DB, Mustafa AS. Identification of a novel protein antigen encoded by a Mycobacterium tuberculosis-specific RD1 region gene. Scand J Immunol 1999; 49:515-22.
36. Colangeli R, Spencer JS, Bifani P, et al. MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infect Immun 2000; 68:990-3.
37. Brusasca PN, Colangeli R, Lyashchenko KP, et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 2001; 54:448-52.
38. Renshaw PS, Panagiotidou P, Whelan A, et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex: Implications for pathogenesis and virulence. J Biol Chem 2002; 277:21598-603.
39. Gey Van Pittius NC, Gamieldien J, Hide W, Brown GD, Siezen RJ, Beyers AD. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol 2001; 2: research0044.1-0044.18.
40. Pallen MJ. The ESAT-6/WXG100 superfamily and a new Gram-positive secretion system? Trends Microbiol 2002; 10:209-12.
41. Lee VT, Schneewind O. Protein secretion and the pathogenesis of bacterial infections. Genes Dev 2001; 15:1725-52.
42. Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR, Bloom BR. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 2000; 68:2888-98.
43. Brandt L, Feino Cunha J, Weinreich Olsen A, et al. Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002; 70:672-8.